Clinical Trials Logo

Cognitive Fatigue clinical trials

View clinical trials related to Cognitive Fatigue.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02721745 Completed - Cognitive Fatigue Clinical Trials

Cause and Consequence of Neural Fatigue

Fatstim
Start date: May 23, 2016
Phase: N/A
Study type: Interventional

While the scientific community understands quite well why muscles ache after prolonged exercise, the origins of mental fatigue remain totally mysterious. Existing theories remain at a psychological level, with scarce supporting evidence. Mental fatigue typically occurs after long episodes during which humans exert control on motor or cognitive processes, instead of executing routine or stimulus-driven behaviours. However, work organization (especially in risky job like airplane control or medical profession) and pathologies due to an overload of work (like burn-out) seems to be directly linked to neural fatigue. One of the consequences of neural fatigue is to alter decision-making. As an example, the choice between an immediate monetary reward and a larger but delayed monetary reward (the so called intertemporal choices) are susceptible to fatigue state of its underpinning neural network. The investigators are proposing an exploratory study of neural fatigue, induced either in a natural way (by performing cognitive tasks for hours) or by transcranial stimulation, using three main physiological measures (Electro-encephalography to measure neural activity, indirect calorimetry to measure the metabolic cost of a cognitive effort, and pupillometry to measure cognitive effort). This study should allow to better understand the consequences of neural fatigue on cognitive functions like decision making as well as the associated physiological variables.

NCT ID: NCT01667497 Completed - Cognitive Fatigue Clinical Trials

Does Fampridine SR Improve Cognitive Fatigue in Multiple Sclerosis Patients?

Start date: September 2012
Phase: Phase 2/Phase 3
Study type: Interventional

Multiple Sclerosis (MS) patients often complain of cognitive fatigue. There is currently no treatment for this symptom. Fampridine SR is a recently approved medication that improves walking ability and walking speed in MS patients. It is thought that it might have the same positive effect on cognitive fatigue. This study will compare fampridine 10mg twice a day to placebo in order to determine if there is any benefit of this medication for cognitive fatigue in MS.